首页>Molecular medicine reports>Candesartan targeting of angiotensin II type I receptor demonstrates benefits for hypertension in pregnancy via the NF-kappa B signaling pathway
Candesartan targeting of angiotensin II type I receptor demonstrates benefits for hypertension in pregnancy via the NF-kappa B signaling pathway